N/A N=21 Treatment

Teaching Academic Success Skills to Students With Autism Spectrum Disorders in Clinical Setting

Autism Spectrum Disorder

Bottom Line

View on ClinicalTrials.gov: NCT03606343 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2020

Primary outcome: Primary: Children's Organizational Skills Scale — 66.14; 57.24 T-Score

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Teaching Academic Skills to Kids (Behavioral)
Age: Pediatric · 11+ yrs
Sex: All
Sponsor: Children's Hospital Medical Center, Cincinnati
Primary completion: Aug 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY Children's Organizational Skills Scale	66.14; 57.24	—
PRIMARY Behavior Rating Inventory of Executive Function - Second Edition	71.86; 66.57	—
PRIMARY Homework Problem Checklist	24.24; 15.71; 8.33; 4.57	—
SECONDARY Woodcock Johnson Tests of Achievement - Third Edition Basic Writing Subtest	103.85; 105.80	—
SECONDARY Classroom Performance Survey	2.02; 1.91	—
SECONDARY Academic Performance Rating System	45.83; 52.11	—
SECONDARY Parenting Relationship Questionnaire - Communication Subscale	41.1; 43.2	—

Summary

The goal of the study is to develop an academic EF intervention, Teaching Academic Skills to Kids (TASK), for high functioning (i.e., IQ score ≥80) middle-school youth with ASD and EF deficits. Aim 1: Use focus group methodology and advice from expert consultants to develop the TASK intervention targeting academic EF skills for middle school youth with ASD that is tailored to the unique needs of these individuals (e.g., content specific to ASD EF deficits, incorporate evidence-based teaching principles and methods for ASD). Aim 2: Examine the feasibility and acceptability of TASK in 3 open trials to assess initial feasibility and efficacy.

Eligibility Criteria

Inclusion Criteria

Diagnosis of autism spectrum disorder
IQ >80
7th grade at time of intervention
mainstreamed classroom
executive functioning problems identified on parent or teacher BRIEF-2

Exclusion Criteria

danger to self or others

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03606343). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.